drugset / Trial / NCT00538863
Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain
Non-randomizedSingle-groupOpen-labelSupportive care
Summary
The purpose of this study was to assess the 90-day safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain in subjects on around-the-clock opioids for their persistent cancer pain.
Timeline
- Start
- 2007-12
- Primary completion
- 2010-10
- Completion
- 2010-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fentanyl | Other / unclassified | 100 ug | Other |
| Subject | Fentanyl | Other / unclassified | 200 ug | Other |
| Subject | Fentanyl | Other / unclassified | 400 ug | Other |
| Subject | Fentanyl | Other / unclassified | 600 ug | Other |
| Subject | Fentanyl | Other / unclassified | 800 ug | Other |
| Subject | Fentanyl | Other / unclassified | 1200 ug | Other |
| Subject | Fentanyl | Other / unclassified | 1600 ug | Other |